{"transactions":[{"id":699142,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T22:47:31.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":17544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2026. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 16,082 shares of common stock issuable pursuant to restricted stock units that have not vested."}],"balance_after":65712,"source":{"system":"sec-edgar","filing":"0001193125-26-331013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000119312526331013/ownership.xml","form_type":"4"}},{"id":751414,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:27:59.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001341125-26-000002","document":"form4-06032026_090653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000134112526000002/form4-06032026_090653.xml","form_type":"4"}},{"id":1015772,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-20T21:00:38.000Z","date":"2025-10-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":57728,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation (\"Parent\"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on October 20, 2025 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share (\"Common Stock\"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the \"Merger Consideration\"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Effective Time, each restricted stock unit with respect to Common Stock (each, a \"Restricted Stock Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each restricted stock unit with respect to Common Stock (each, a \"Restricted Stock Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each restricted stock unit with respect to Common Stock (each, a \"Restricted Stock Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Dr. Kuntz."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each restricted stock unit with respect to Common Stock (each, a \"Restricted Stock Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Dr. Kuntz."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57728},"source":{"system":"sec-edgar","filing":"0001193125-25-243727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000119312525243727/ownership.xml","form_type":"4"}},{"id":1015771,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2025-10-20T21:00:38.000Z","date":"2025-10-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13072.965,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation (\"Parent\"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on October 20, 2025 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share (\"Common Stock\"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the \"Merger Consideration\"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a \"Deferred Share Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a \"Deferred Share Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a \"Deferred Share Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Dr. Kuntz."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a \"Deferred Share Unit\") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Dr. Kuntz."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13072.965},"source":{"system":"sec-edgar","filing":"0001193125-25-243727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000119312525243727/ownership.xml","form_type":"4"}},{"id":1026621,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2025-10-02T20:09:15.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":662.309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (the \"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Securities is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":13072.965,"derivative":{"exercise_price":18.93,"underlying":"Common Stock","underlying_shares":662.309},"source":{"system":"sec-edgar","filing":"0001341125-25-000005","document":"form4-10022025_081012.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000134112525000005/form4-10022025_081012.xml","form_type":"4"}},{"id":1078536,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-31T20:52:01.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":21148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2025. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 19,386 shares of common stock issuable pursuant to restricted stock units that have not vested."}],"balance_after":48168,"source":{"system":"sec-edgar","filing":"0000950170-25-100967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000095017025100967/ownership.xml","form_type":"4"}},{"id":1094541,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2025-07-02T20:36:01.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":1340.909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":12410.656,"derivative":{"exercise_price":9.35,"underlying":"Common Stock","underlying_shares":1340.909},"source":{"system":"sec-edgar","filing":"0001062993-25-012468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299325012468/form4.xml","form_type":"4"}},{"id":1124619,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:16:41.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019291","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019291/rdgdoc.xml","form_type":"4"}},{"id":1153423,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-09T21:34:27.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":21119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."}],"balance_after":57728,"derivative":{"underlying":"Common Stock","underlying_shares":21119},"source":{"system":"sec-edgar","filing":"0001062993-25-009038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299325009038/form4.xml","form_type":"4"}},{"id":1153422,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2025-05-09T21:34:27.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":11069.747,"derivative":{"exercise_price":8.76,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001062993-25-009038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299325009038/form4.xml","form_type":"4"}},{"id":1182828,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2025-04-02T21:22:27.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":1163.033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":10569.747,"derivative":{"exercise_price":10.78,"underlying":"Common Stock","underlying_shares":1163.033},"source":{"system":"sec-edgar","filing":"0001062993-25-006867","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299325006867/form4.xml","form_type":"4"}},{"id":1314218,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:28:57.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":9925,"price":5.34,"value":52999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,000.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,925 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan."}],"balance_after":24210,"source":{"system":"sec-edgar","filing":"0001235802-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000003/primary_doc.xml","form_type":"4"}},{"id":1313917,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2025-01-03T15:01:28.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":894.897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":9406.714,"derivative":{"exercise_price":14.01,"underlying":"Common Stock","underlying_shares":894.897},"source":{"system":"sec-edgar","filing":"0001062993-25-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299325000044/form4.xml","form_type":"4"}},{"id":1382533,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-23T23:41:21.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":14773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2024. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service."}],"balance_after":27020,"source":{"system":"sec-edgar","filing":"0000950170-24-116778","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000095017024116778/ownership.xml","form_type":"4"}},{"id":1393880,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2024-10-02T20:09:59.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":795.022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":8511.817,"derivative":{"exercise_price":15.77,"underlying":"Common Stock","underlying_shares":795.022},"source":{"system":"sec-edgar","filing":"0001062993-24-017242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299324017242/form4.xml","form_type":"4"}},{"id":1462310,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2024-07-02T20:38:53.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":696.915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":7716.795,"derivative":{"exercise_price":17.99,"underlying":"Common Stock","underlying_shares":696.915},"source":{"system":"sec-edgar","filing":"0001062993-24-013315","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299324013315/form4.xml","form_type":"4"}},{"id":1494972,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:09:40.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000045","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000045/primary_doc.xml","form_type":"4"}},{"id":1510781,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:14:22.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":11012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."}],"balance_after":36609,"derivative":{"underlying":"Common Stock","underlying_shares":11012},"source":{"system":"sec-edgar","filing":"0001062993-24-010620","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299324010620/form4.xml","form_type":"4"}},{"id":1510780,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2024-05-17T20:14:22.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":7019.88,"derivative":{"exercise_price":16.8,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001062993-24-010620","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299324010620/form4.xml","form_type":"4"}},{"id":1552911,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2024-04-02T20:05:45.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":764.016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash after cessation of the reporting person's service as a Director."}],"balance_after":6519.88,"derivative":{"exercise_price":16.41,"underlying":"Common Stock","underlying_shares":764.016},"source":{"system":"sec-edgar","filing":"0001062993-24-007700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299324007700/form4.xml","form_type":"4"}},{"id":1696367,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T22:00:26.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":14285,"price":2.8,"value":39998.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $40,000.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $40,000.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":14285,"source":{"system":"sec-edgar","filing":"0001235802-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000004/primary_doc.xml","form_type":"4"}},{"id":1818224,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-02T16:24:50.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":8904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2023. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service."}],"balance_after":12247,"source":{"system":"sec-edgar","filing":"0000950170-23-036915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000095017023036915/ownership.xml","form_type":"4"}},{"id":1835432,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2023-07-05T21:21:55.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":762.86,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":5755.864,"derivative":{"exercise_price":11.47,"underlying":"Common Stock","underlying_shares":762.86},"source":{"system":"sec-edgar","filing":"0001062993-23-014502","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299323014502/form4.xml","form_type":"4"}},{"id":1874561,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-30T22:18:41.000Z","date":"2023-05-30","kind":"grant","planned":false,"acquired":true,"shares":32320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in 12 nearly equal quarterly installments over three years."}],"balance_after":32320,"derivative":{"exercise_price":2.81,"expiration_date":"2033-05-29","underlying":"Common Shares","underlying_shares":32320},"source":{"system":"sec-edgar","filing":"0001790300-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000179030023000003/primary_doc.xml","form_type":"4"}},{"id":1891123,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-16T20:43:14.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":17704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."}],"balance_after":25597,"derivative":{"underlying":"Common Stock","underlying_shares":17704},"source":{"system":"sec-edgar","filing":"0001062993-23-011240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299323011240/form4.xml","form_type":"4"}},{"id":1891122,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2023-05-16T20:43:14.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":4993.004,"derivative":{"exercise_price":10.45,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001062993-23-011240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299323011240/form4.xml","form_type":"4"}},{"id":1927202,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2023-04-04T20:02:27.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":1241.135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":4493.004,"derivative":{"exercise_price":7.05,"underlying":"Common Stock","underlying_shares":1241.135},"source":{"system":"sec-edgar","filing":"0001062993-23-008463","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299323008463/form4.xml","form_type":"4"}},{"id":2066219,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2023-01-04T21:03:30.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":957.33,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":3251.869,"derivative":{"exercise_price":9.14,"underlying":"Common Stock","underlying_shares":957.33},"source":{"system":"sec-edgar","filing":"0001062993-23-000240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299323000240/form4.xml","form_type":"4"}},{"id":2127450,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-02T20:59:44.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":3343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vest on a monthly basis beginning on the vesting commencement date of October 18, 2022 through May 31, 2023. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service."}],"balance_after":3343,"source":{"system":"sec-edgar","filing":"0000899243-22-034775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000089924322034775/doc4.xml","form_type":"4"}},{"id":2143907,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2022-10-04T20:05:17.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":870.647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":2294.539,"derivative":{"exercise_price":10.05,"underlying":"Common Stock","underlying_shares":870.647},"source":{"system":"sec-edgar","filing":"0001062993-22-020310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299322020310/form4.xml","form_type":"4"}},{"id":2170049,"issuer":{"id":122956,"kind":"organization","name":"Rockley Photonics Holdings Ltd","symbol":"RKLY"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-08-31T18:59:56.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":60837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service as a director, the RSU will vest on the earlier of the one-year anniversary of the date of grant or the 2023 annual meeting of shareholders, subject to acceleration upon a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to continued service as a director, the RSU will vest on the earlier of the one-year anniversary of the date of grant or the 2023 annual meeting of shareholders, subject to acceleration upon a change in control."}],"balance_after":60837,"derivative":{"exercise_price":0,"underlying":"Ordinary Share","underlying_shares":60837},"source":{"system":"sec-edgar","filing":"0001852117-22-000316","document":"wf-form4_166198678274486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852117/000185211722000316/wf-form4_166198678274486.xml","form_type":"4"}},{"id":2189664,"issuer":{"id":122956,"kind":"organization","name":"Rockley Photonics Holdings Ltd","symbol":"RKLY"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:19:14.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":107317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Subject to continued service as a director, the RSU vests as to 1/3 of the shares upon the earlier of the first anniversary of the date of grant or the Company's 2023 annual meeting of shareholders, and in each of the next two calendar years following the initial vesting date, 1/3 of the shares will vest on the earlier of the one year anniversary of the prior annual meeting of shareholders or the then current year's annual meeting of shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service as a director, the RSU vests as to 1/3 of the shares upon the earlier of the first anniversary of the date of grant or the Company's 2023 annual meeting of shareholders, and in each of the next two calendar years following the initial vesting date, 1/3 of the shares will vest on the earlier of the one year anniversary of the prior annual meeting of shareholders or the then current year's annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to continued service as a director, the RSU vests as to 1/3 of the shares upon the earlier of the first anniversary of the date of grant or the Company's 2023 annual meeting of shareholders, and in each of the next two calendar years following the initial vesting date, 1/3 of the shares will vest on the earlier of the one year anniversary of the prior annual meeting of shareholders or the then current year's annual meeting of shareholders."}],"balance_after":107317,"derivative":{"underlying":"Ordinary Share","underlying_shares":107317},"source":{"system":"sec-edgar","filing":"0001852117-22-000266","document":"wf-form4_166017713817248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852117/000185211722000266/wf-form4_166017713817248.xml","form_type":"4"}},{"id":2214111,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2022-07-05T20:04:01.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":541.796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":1423.892,"derivative":{"exercise_price":16.15,"underlying":"Common Stock","underlying_shares":541.796},"source":{"system":"sec-edgar","filing":"0001062993-22-015846","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299322015846/form4.xml","form_type":"4"}},{"id":2307504,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-04T21:17:42.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":7893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."}],"balance_after":7893,"derivative":{"underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001062993-22-009504","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299322009504/form4.xml","form_type":"4"}},{"id":2307503,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2022-04-04T21:17:42.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":882.096,"derivative":{"exercise_price":23.44,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001062993-22-009504","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299322009504/form4.xml","form_type":"4"}},{"id":2307502,"issuer":{"id":74112,"kind":"organization","name":"ZimVie Inc.","symbol":"ZIMV"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2022-04-04T21:17:42.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":382.096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The deferred share units were accrued under the ZimVie Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":382.096,"derivative":{"exercise_price":22.9,"underlying":"Common Stock","underlying_shares":382.096},"source":{"system":"sec-edgar","filing":"0001062993-22-009504","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000106299322009504/form4.xml","form_type":"4"}},{"id":2519380,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2021-11-09T22:58:19.000Z","date":"2021-11-05","kind":"tax_withholding","acquired":false,"shares":209,"price":122.98,"value":25702.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 239 shares due to exempt transactions such as dividend reinvestment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported transaction involved the withholding of 209 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible."}],"balance_after":74945,"source":{"system":"sec-edgar","filing":"0001127602-21-028739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760221028739/form4.xml","form_type":"4"}},{"id":2614459,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Performance Share Units","published_at":"2021-08-04T22:16:58.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":12571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance share unit represents a contingent right to receive one share of Medtronic common stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"The number of shares to be issued  in connection with the performance share units (\"PSUs\") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,571 shares will be issued. The actual number of shares to be issued could range from a low of 2,515 at minimum performance to a high of 25,142 shares at maximum performance.  If minimum performance metrics are not met, such PSUs may vest at 0 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vests on August 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Vests on August 2, 2024."}],"balance_after":12571,"derivative":{"underlying":"Performance Share Units","underlying_shares":12571},"source":{"system":"sec-edgar","filing":"0001127602-21-023100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760221023100/form4.xml","form_type":"4"}},{"id":2614458,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T22:16:58.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":1085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1085,"derivative":{"exercise_price":131.26,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Ordinary Shares","underlying_shares":1085},"source":{"system":"sec-edgar","filing":"0001127602-21-023100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760221023100/form4.xml","form_type":"4"}},{"id":2614457,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T22:16:58.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":42961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":42961,"derivative":{"exercise_price":131.26,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Ordinary Shares","underlying_shares":42961},"source":{"system":"sec-edgar","filing":"0001127602-21-023100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760221023100/form4.xml","form_type":"4"}},{"id":2614456,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2021-08-04T22:16:58.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":5029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date."}],"balance_after":74915,"source":{"system":"sec-edgar","filing":"0001127602-21-023100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760221023100/form4.xml","form_type":"4"}},{"id":2614455,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2021-08-04T22:16:58.000Z","date":"2021-08-02","kind":"tax_withholding","acquired":false,"shares":4905,"price":131.31,"value":644075.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 782 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":69886,"source":{"system":"sec-edgar","filing":"0001127602-21-023100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760221023100/form4.xml","form_type":"4"}},{"id":2990867,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2020-11-05T22:59:09.000Z","date":"2020-11-03","kind":"tax_withholding","acquired":false,"shares":273,"price":103.13,"value":28154.49,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 281 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":74009,"source":{"system":"sec-edgar","filing":"0001127602-20-028279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220028279/form4.xml","form_type":"4"}},{"id":3006922,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Performance Share Units","published_at":"2020-10-14T22:47:46.000Z","date":"2020-10-09","kind":"grant","acquired":true,"shares":14723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of Medtronic common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares to be issued  in connection with the performance share units (\"PSUs\") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,723 shares will be issued. The actual number of shares to be issued could range from a low of 2,945 at minimum performance to a high of 29,446 shares at maximum performance.  If minimum performance metrics are not met, such PSUs may vest at 0 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests on August 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vests on August 3, 2023."}],"balance_after":14723,"derivative":{"underlying":"Performance Share Units","underlying_shares":14723},"source":{"system":"sec-edgar","filing":"0001127602-20-026953","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220026953/form4.xml","form_type":"4"}},{"id":3067027,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:57:16.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":36524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":36524,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":36524},"source":{"system":"sec-edgar","filing":"0001127602-20-022899","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220022899/form4.xml","form_type":"4"}},{"id":3067026,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:57:16.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":1575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1575,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":1575},"source":{"system":"sec-edgar","filing":"0001127602-20-022899","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220022899/form4.xml","form_type":"4"}},{"id":3067025,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:57:16.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":60453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":60453,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":60453},"source":{"system":"sec-edgar","filing":"0001127602-20-022899","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220022899/form4.xml","form_type":"4"}},{"id":3067024,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2020-08-05T20:57:16.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":6576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date."}],"balance_after":74001,"source":{"system":"sec-edgar","filing":"0001127602-20-022899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220022899/form4.xml","form_type":"4"}},{"id":3071168,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:43:07.000Z","date":"2020-07-31","kind":"tax_withholding","acquired":false,"shares":4482,"price":96.48,"value":432423.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 894 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":67425,"source":{"system":"sec-edgar","filing":"0001127602-20-022592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760220022592/form4.xml","form_type":"4"}},{"id":3330994,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"exercise","acquired":false,"shares":38558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option to purchase 38,558 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 38,558 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":55.32,"expiration_date":"2023-07-29","underlying":"Ordinary Shares","underlying_shares":38558},"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330993,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"exercise","acquired":false,"shares":1808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 1,808 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":55.32,"expiration_date":"2023-07-29","underlying":"Ordinary Shares","underlying_shares":1808},"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330992,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"exercise","acquired":false,"shares":2404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":41.6,"expiration_date":"2022-10-29","underlying":"Ordinary Shares","underlying_shares":2404},"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330991,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":38558,"price":113.56,"value":4378646.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.48 to $113.66, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":71013,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330990,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"exercise","acquired":true,"shares":38558,"price":55.32,"value":2133028.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":109571,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330989,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":1808,"price":113.66,"value":205497.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":71013,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330988,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"exercise","acquired":true,"shares":1808,"price":55.32,"value":100018.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":72821,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330987,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":2404,"price":113.6,"value":273094.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":71013,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330986,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"exercise","acquired":true,"shares":2404,"price":41.6,"value":100006.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":73417,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330985,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":3019,"price":113.63,"value":343048.97,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":71013,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3330984,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-12-26T22:36:54.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":5067,"price":113.64,"value":575813.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 283 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":74032,"source":{"system":"sec-edgar","filing":"0001127602-19-035863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219035863/form4.xml","form_type":"4"}},{"id":3404227,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-09-30T21:52:21.000Z","date":"2019-09-27","kind":"sale","acquired":false,"shares":100,"price":108.21,"value":10821.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":78816,"source":{"system":"sec-edgar","filing":"0001127602-19-029262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219029262/form4.xml","form_type":"4"}},{"id":3404226,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-09-30T21:52:21.000Z","date":"2019-09-27","kind":"sale","acquired":false,"shares":21325,"price":107.511,"value":2292672.075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $107.02 to $107.95, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":78916,"source":{"system":"sec-edgar","filing":"0001127602-19-029262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219029262/form4.xml","form_type":"4"}},{"id":3448827,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-08-02T22:29:43.000Z","date":"2019-08-02","kind":"sale","acquired":false,"shares":5719,"price":102.02,"value":583452.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":100241,"source":{"system":"sec-edgar","filing":"0001127602-19-025932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219025932/form4.xml","form_type":"4"}},{"id":3448826,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-08-02T22:29:43.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":4795,"price":102.37,"value":490864.15,"ownership":{"direct":true},"balance_after":105960,"source":{"system":"sec-edgar","filing":"0001127602-19-025932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219025932/form4.xml","form_type":"4"}},{"id":3451832,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T21:56:03.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":1615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1615,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":1615},"source":{"system":"sec-edgar","filing":"0001127602-19-025555","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219025555/form4.xml","form_type":"4"}},{"id":3451831,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T21:56:03.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":68901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":68901,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":68901},"source":{"system":"sec-edgar","filing":"0001127602-19-025555","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219025555/form4.xml","form_type":"4"}},{"id":3451830,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-07-31T21:56:03.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":10330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 298 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":110755,"source":{"system":"sec-edgar","filing":"0001127602-19-025555","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219025555/form4.xml","form_type":"4"}},{"id":3457314,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-07-23T22:03:52.000Z","date":"2019-07-22","kind":"sale","acquired":false,"shares":3438,"price":101.12,"value":347650.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 324 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":100127,"source":{"system":"sec-edgar","filing":"0001127602-19-025080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219025080/form4.xml","form_type":"4"}},{"id":3492411,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-06-12T22:09:34.000Z","date":"2019-03-20","kind":"gift","acquired":false,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This balance increased by 616 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":103241,"source":{"system":"sec-edgar","filing":"0001127602-19-021490","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219021490/form4a.xml","form_type":"4/A","original_submission_date":"2019-03-29"}},{"id":3573879,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2019-03-29T21:11:17.000Z","date":"2019-03-20","kind":"gift","acquired":false,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This balance increased by 616 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":103241,"source":{"system":"sec-edgar","filing":"0001127602-19-013603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760219013603/form4.xml","form_type":"4"}},{"id":3830252,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-29T20:38:41.000Z","date":"2018-08-28","kind":"exercise","acquired":false,"shares":41227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option to purchase 41,227 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,227 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":38.81,"expiration_date":"2022-07-30","underlying":"Ordinary Shares","underlying_shares":41227},"source":{"system":"sec-edgar","filing":"0001127602-18-026464","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218026464/form4.xml","form_type":"4"}},{"id":3830251,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2018-08-29T20:38:41.000Z","date":"2018-08-28","kind":"sale","acquired":false,"shares":47176,"price":95.8769,"value":4523088.6344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price.  These shares were sold in multiple transactions in prices ranging from $95.82 to $95.9850, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4."}],"balance_after":105403,"source":{"system":"sec-edgar","filing":"0001127602-18-026464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218026464/form4.xml","form_type":"4"}},{"id":3830250,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2018-08-29T20:38:41.000Z","date":"2018-08-28","kind":"exercise","acquired":true,"shares":41227,"price":38.81,"value":1600019.87,"ownership":{"direct":true},"balance_after":152579,"source":{"system":"sec-edgar","filing":"0001127602-18-026464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218026464/form4.xml","form_type":"4"}},{"id":3850618,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2018-08-07T20:34:55.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":4987,"price":90.48,"value":451223.76,"ownership":{"direct":true},"balance_after":111352,"source":{"system":"sec-edgar","filing":"0001127602-18-024847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218024847/form4.xml","form_type":"4"}},{"id":3856556,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T19:49:56.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":1695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1695,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":1695},"source":{"system":"sec-edgar","filing":"0001127602-18-024242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218024242/form4.xml","form_type":"4"}},{"id":3856555,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T19:49:56.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":61004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":61004,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":61004},"source":{"system":"sec-edgar","filing":"0001127602-18-024242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218024242/form4.xml","form_type":"4"}},{"id":3856554,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2018-08-01T19:49:56.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":10104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This balance increased by 312 shares due to exempt transactions such as dividend reinvestment."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":116339,"source":{"system":"sec-edgar","filing":"0001127602-18-024242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218024242/form4.xml","form_type":"4"}},{"id":3898080,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SVP & Chief Medical & Science"}}],"security":"Ordinary Shares","published_at":"2018-06-11T20:36:51.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":11500,"price":87.13,"value":1001995.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price.  These shares were sold in multiple transactions in prices ranging from $87.09 to $87.155, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 316 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":105923,"source":{"system":"sec-edgar","filing":"0001127602-18-020614","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218020614/form4.xml","form_type":"4"}},{"id":4101877,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-10T22:40:24.000Z","date":"2018-01-09","kind":"exercise","acquired":false,"shares":45872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 45,872 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 45,872 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":34.88,"expiration_date":"2021-08-01","underlying":"Ordinary Shares","underlying_shares":45872},"source":{"system":"sec-edgar","filing":"0001127602-18-001566","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218001566/form4.xml","form_type":"4"}},{"id":4101876,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-10T22:40:24.000Z","date":"2018-01-09","kind":"exercise","acquired":false,"shares":35492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 35,492 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 35,492 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":37.53,"expiration_date":"2020-08-02","underlying":"Ordinary Shares","underlying_shares":35492},"source":{"system":"sec-edgar","filing":"0001127602-18-001566","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218001566/form4.xml","form_type":"4"}},{"id":4101875,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2018-01-10T22:40:24.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":78526,"price":86.21,"value":6769726.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This balance increased by 324 shares due to exempt transactions such as dividend reinvestment."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $86.12 to $86.26, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."}],"balance_after":117107,"source":{"system":"sec-edgar","filing":"0001127602-18-001566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218001566/form4.xml","form_type":"4"}},{"id":4101874,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2018-01-10T22:40:24.000Z","date":"2018-01-09","kind":"exercise","acquired":true,"shares":45872,"price":34.88,"value":1600015.36,"ownership":{"direct":true},"balance_after":195633,"source":{"system":"sec-edgar","filing":"0001127602-18-001566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218001566/form4.xml","form_type":"4"}},{"id":4101873,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2018-01-10T22:40:24.000Z","date":"2018-01-09","kind":"exercise","acquired":true,"shares":35492,"price":37.53,"value":1332014.76,"ownership":{"direct":true},"balance_after":149761,"source":{"system":"sec-edgar","filing":"0001127602-18-001566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760218001566/form4.xml","form_type":"4"}},{"id":4245387,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T19:05:20.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1191,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":1191},"source":{"system":"sec-edgar","filing":"0001127602-17-024715","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760217024715/form4.xml","form_type":"4"}},{"id":4245386,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T19:05:20.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":41285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":41285,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":41285},"source":{"system":"sec-edgar","filing":"0001127602-17-024715","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760217024715/form4.xml","form_type":"4"}},{"id":4245385,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:05:20.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":10322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":113945,"source":{"system":"sec-edgar","filing":"0001127602-17-024715","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760217024715/form4.xml","form_type":"4"}},{"id":4247098,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2017-08-01T16:43:55.000Z","date":"2017-07-28","kind":"tax_withholding","acquired":false,"shares":4621,"price":84.29,"value":389504.09,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 1159 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":103623,"source":{"system":"sec-edgar","filing":"0001127602-17-024470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760217024470/form4.xml","form_type":"4"}},{"id":4593198,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-28T20:25:38.000Z","date":"2016-09-26","kind":"exercise","acquired":false,"shares":30624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 30,624 New Medtronic ordinary shares for $35.92 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,624 Medtronic common stock shares for $35.92 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":35.92,"expiration_date":"2019-08-03","underlying":"Ordinary Shares","underlying_shares":30624},"source":{"system":"sec-edgar","filing":"0001127602-16-063340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760216063340/form4.xml","form_type":"4"}},{"id":4593197,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2016-09-28T20:25:38.000Z","date":"2016-09-27","kind":"sale","acquired":false,"shares":17141,"price":86.696,"value":1486056.136,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.675 to $86.725, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":107085,"source":{"system":"sec-edgar","filing":"0001127602-16-063340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760216063340/form4.xml","form_type":"4"}},{"id":4593196,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2016-09-28T20:25:38.000Z","date":"2016-09-26","kind":"sale","acquired":false,"shares":25199,"price":86.67,"value":2183997.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price.  These shares were sold in multiple transactions in prices ranging from $86.57 to $86.735, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4."}],"balance_after":124226,"source":{"system":"sec-edgar","filing":"0001127602-16-063340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760216063340/form4.xml","form_type":"4"}},{"id":4593195,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":27277,"kind":"person","name":"Kuntz Richard","position":1,"cik":"0001341125","reported_name":"Kuntz Richard","relationship":{"officer":true,"officer_title":"SrVP & Chief Scien, Clin, Reg"}}],"security":"Ordinary Shares","published_at":"2016-09-28T20:25:38.000Z","date":"2016-09-26","kind":"exercise","acquired":true,"shares":30624,"price":35.92,"value":1100014.08,"ownership":{"direct":true},"balance_after":149425,"source":{"system":"sec-edgar","filing":"0001127602-16-063340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341125/000112760216063340/form4.xml","form_type":"4"}}]}